Get the Stockscreener App
81.01
1.71%
-1.41
After Hours:
81.01
Solventum Corp stock is traded at $81.01, with a volume of 1.73M.
It is down -1.71% in the last 24 hours and up +17.34% over the past month.
Solventum Corp is a healthcare company developing, manufacturing, and commercializing solutions leveraging material science, data science, and digital capabilities to address customer and patient needs. Its segments include MedSurg, which earns maximum revenue and provides wound therapy, I.V. site management, surgical supplies, medical tapes and wraps, stethoscopes, medical electrodes, and OEM medical technologies; Dental Solutions, offering dental and orthodontic products such as brackets, restorative cements, and bonding agents; and Health Information Systems, providing software solutions including physician documentation, coding automation, speech recognition, and data visualization platforms. It operates in the United States, which earns the majority of revenue, and internationally.
See More
Previous Close:
$82.42
Open:
$83.01
24h Volume:
1.73M
Relative Volume:
1.04
Market Cap:
$14.03B
Revenue:
$8.28B
Net Income/Loss:
$1.43B
P/E Ratio:
9.9226
EPS:
8.1642
Net Cash Flow:
$-203.00M
1W Performance:
+8.09%
1M Performance:
+17.34%
6M Performance:
-5.17%
1Y Performance:
+7.48%
1-Day Range:
$80.64
$83.42
1-Week Range:
$74.33
$83.42
52-Week Range:
$62.38
$88.20
Solventum Corp Stock (SOLV) Company Profile
Name
Solventum Corp
Sector
Industry
Phone
651-733-1110
Address
1750 YANKEE DOODLE ROAD, EAGAN
Compare SOLV vs ISRG, BDX, ALC, RMD, MDLN
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SOLV
Solventum Corp
|
81.01 | 14.27B | 8.28B | 1.43B | -203.00M | 8.1642 |
ISRG
Intuitive Surgical Inc
|
422.06 | 148.33B | 10.58B | 3.00B | 2.83B | 8.2437 |
BDX
Becton Dickinson Co
|
151.16 | 41.21B | 21.37B | 1.41B | 3.07B | 3.9437 |
ALC
Alcon Inc
|
66.81 | 32.47B | 10.63B | 819.00M | 1.59B | 1.6577 |
RMD
Resmed Inc
|
196.04 | 28.19B | 5.54B | 1.52B | 1.74B | 10.37 |
MDLN
Medline Inc
|
33.61 | 29.13B | 29.14B | 1.07B | 1.05B | 1.1956 |
Solventum Corp Stock (SOLV) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-24-26 | Initiated | Rothschild & Co Redburn | Sell |
| Jan-26-26 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Jan-20-26 | Upgrade | Mizuho | Neutral → Outperform |
| Dec-02-25 | Upgrade | BTIG Research | Neutral → Buy |
| Oct-01-25 | Initiated | UBS | Neutral |
| Sep-11-25 | Initiated | Jefferies | Hold |
| Jul-15-25 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Jul-01-25 | Upgrade | Argus | Hold → Buy |
| Jun-06-25 | Initiated | KeyBanc Capital Markets | Sector Weight |
| May-19-25 | Upgrade | Piper Sandler | Neutral → Overweight |
| Dec-04-24 | Initiated | Mizuho | Neutral |
| Oct-08-24 | Initiated | Stifel | Buy |
| Oct-07-24 | Initiated | Piper Sandler | Neutral |
| Sep-26-24 | Initiated | Wolfe Research | Peer Perform |
| Sep-05-24 | Initiated | BTIG Research | Neutral |
| Jun-24-24 | Initiated | Argus | Hold |
| May-30-24 | Initiated | Goldman | Sell |
| May-10-24 | Initiated | BofA Securities | Neutral |
| Apr-10-24 | Initiated | Morgan Stanley | Equal-Weight |
| Apr-08-24 | Initiated | Wells Fargo | Equal Weight |
| Apr-02-24 | Initiated | Edward Jones | Hold |
View All
Solventum Corp Stock (SOLV) Latest News
Assessing Solventum (SOLV) Valuation As AI Disruption Fears Challenge Health Information Systems Prospects - simplywall.st
Solventum (SOLV) Q1 2026 Earnings Transcript - AOL.com
Solventum Corporation 8-K Filing: Company Details, Address, Ticker, and Exchange Information (June 2, 2026) - Minichart
Why Solventum (SOLV) Is Up 8.1% After Q1 Beat And $1 Billion Buyback Announcement - simplywall.st
Solventum Corp. stock rises Thursday, outperforms market - MSN
Solventum Resolves Bylaw Litigation and Case Closed - TipRanks
Solventum (NYSE: SOLV) closes By-law challenge with $120K mootness fee payment - Stock Titan
Solventum executive pay disclosure includes $11M severance for ex-MedSurg leader - Medical Design & Outsourcing
Solventum Corporation (SOLV) Fell as Its HCIT Unit Hurt by AI Disruption Fears - Yahoo Finance
Executives at Solventum commute to Minnesota by plane. A shareholder wants to change that - MSN
Solventum Corp. stock rises Wednesday, outperforms market - MarketWatch
SOLV Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Solventum Corp. stock rises Monday, outperforms market - MarketWatch
Solventum Corporation (SOLV) Stock Analysis: Strong Return on Equity and Investor Ratings Signal Potential Growth - DirectorsTalk Interviews
3M Company stock (US88579Y1010): technical picture in focus after Solventum spin-off and PFAS headli - AD HOC NEWS
3M Company stock (US88579Y1010): shares react to recent spin-off of Solventum and technical picture - AD HOC NEWS
Solventum (SOLV) recently broke out above the 200-day moving average - MSN
Solventum Corp. stock falls Friday, underperforms market - MarketWatch
Trian Presses Solventum Over Private‑Jet Exec Commutes - Hoodline
Minnesota’s Solventum to pay $1.6M fine for selling equipment to Chinese firms - MSN
Executives at this Minnesota company commute here by plane. A shareholder wants to change that. - Star Tribune
Solventum (SOLV) Q4 2025 Earnings Call Transcript - Fortune
Solventum Adopts Updated Executive Severance and Compensation Plan - The Globe and Mail
Solventum Corporation 8-K Filing: Executive Severance Plan, Key Company Information & NYSE Listing (2026) - Minichart
3M Company stock (US88579Y1010): Spin-off of Solventum reshapes the conglomerate - AD HOC NEWS
Executive severance revised at Solventum (NYSE: SOLV) with new pay and benefits - Stock Titan
Solventum to Participate in the 2026 Jefferies Healthcare Conference - PR Newswire
Goldman Sachs Adjusts Price Target on Solventum to $67 From $66, Maintains Sell Rating - marketscreener.com
Jefferies healthcare conference to feature Solventum live chat - Stock Titan
3M Company stock (US88579Y1010): Spin-off of Solventum reshapes the industrial giant - AD HOC NEWS
Analysts Offer Insights on Healthcare Companies: Bristol-Myers Squibb (BMY), BillionToOne, Inc. Class A (BLLN) and Solventum Corporation (SOLV) - The Globe and Mail
Solventum Beats Consensus Estimates for 1Q26 - Medical Device and Diagnostic industry
Solventum Corporation (SOLV) Stock Report: Is A 6.83% Upside Worth The Dive? - DirectorsTalk Interviews
3M Company stock (US88579Y1010): spin-off, earnings pressure and legal risks in focus - AD HOC NEWS
Assessing Solventum (SOLV) Valuation As Recent Momentum Meets Perceived Undervaluation - simplywall.st
Solventum stock is recovering: What's going on? - MSN
3M Company stock (US88579Y1010): Q1 2026 earnings and Solventum spin-off reshape the industrial gian - AD HOC NEWS
Solventum Shareholders Back Board, Pay and Auditor Choices - TipRanks
Solventum (NYSE: SOLV) shareholders approve directors, pay plan and PwC auditor - Stock Titan
Solventum Corp. stock falls Tuesday, underperforms market - MarketWatch
Will Activist Pressure and Reaffirmed EPS Guidance Reshape Solventum's (SOLV) Transformation Narrative? - simplywall.st
What Are Wall Street Analysts' Target Price for Solventum Stock? - Barchart.com
Solventum gains after activist Trian sends letter urging changes (update) - MSN
Solventum (SOLV) director Carlos Alban receives 3,300 restricted stock units - Stock Titan
Solventum Corp (SOLV) director receives 4,848 restricted stock units - Stock Titan
Solventum (SOLV) director Susan DeVore awarded 3,300 restricted stock units - Stock Titan
Solventum (SOLV) director receives 3,300 Restricted Stock Units as equity grant - Stock Titan
Director Glenn Eisenberg receives 3,300 Solventum (SOLV) restricted stock units - Stock Titan
Solventum (SOLV) director awarded 3,300 RSUs vesting in 2027 - Stock Titan
Solventum (SOLV) director Karen May receives grant of 3,300 RSUs - Stock Titan
Director at Solventum (NYSE: SOLV) receives 3,300 RSU equity grant - Stock Titan
Solventum Corp Stock (SOLV) Financials Data
Revenue
Net Income
Cash Flow
EPS
8.58%
0.33%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):